Preventive medicine is a medical practice based on the principle that prevention is better than cure. Preventive medicine can reduce the incidence of non-communicable diseases such as cancer, cardiovascular disease and diabetes.

Market Analysis and Insights: Global Preventive Medicine Market
The global Preventive Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preventive Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preventive Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preventive Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preventive Medicine market.

Global Preventive Medicine Scope and Market Size
Preventive Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preventive Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Public Health and General Preventive Medicine
Occupational Medicine
Military Preventive Medicine

Segment by Application
Hospital
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novo Nordisk
Eli Lilly
Quanterix
Preventive Medical Health Care
Cancer Prevention Pharmaceuticals
Phoenix Medicine
U.S. Preventive Medicine